Zai Lab:Zai Lab Limited (ZLAB) 股價、新聞、報價和過往記錄
Zai Lab Limited (ZLAB) 股價、新聞、報價和過往記錄
About Zai Lab
https://www.zailaboratory.com
Zai Lab is a patient-focused, innovative, commercial-stage, global biopharmaceutical company based in China and the U.S. We are focused on bringing ...
Products
https://www.zailaboratory.com
Zai Lab currently sells ZEJULA in mainland China, Hong Kong and Macau as a first-line maintenance treatment for ovarian cancer and a maintenance treatment for ...
Zai Lab (US) LLC
https://www.biospace.com
Zai Lab is an innovative commercial stage biopharmaceutical company focused on bringing transformative medicines for cancer, infectious and autoimmune ...
Zai Lab Limited (ZLAB) Stock Price
https://finance.yahoo.com
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience.
Zai Lab Limited
https://ir.zailaboratory.com
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States.
Zai Lab
https://www.zailaboratory.com
Zai Lab is an innovative, research-based, commercial stage biopharmaceutical company based in China and the U.S. focused on bringing transformative medicines ...
ZLAB-Zai Lab Limited(再鼎醫藥有限公司)
https://www.moneydj.com
Zai Lab Limited(再鼎醫藥有限公司)成立於2017年3月28日,為一家生物製藥公司,專注於發現或授權、開發及商品化專利療法,以解決中國市場大量未滿足的醫療需求,包含腫瘤、自體 ...
投資者概覽
https://ir.zailaboratory.com
再鼎醫藥(納斯達克股票代碼:ZLAB;香港聯交所股份代號:9688)是一家總部位於中國和美國、以研發為基礎、處於商業化階段的創新型生物製藥公司,專注於為中國及全球患者提供 ...
新聞稿
https://zailab.gcs-web.com
Zai Lab to Present Preliminary Data From Phase 1 Trial of ZL-1218, an Investigational Anti-CCR8 Antibody for the Treatment of Advanced Solid Tumors, ...